Showing results (151-160 of 1,687) with videos related to
Sort By:
Pageof 169
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant AccrualChad Tang, Kenneth R Hess, Dwana Sanders, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2011
Micromanaging the classification of colon cancer: the role of the microRNAomeEduardo Vilar, Josep Tabernero, Stephen B GruberMolecular Cancer Therapeutics|January 11, 2011
Pushing the envelope in the mTOR pathway: the second generation of inhibitorsEduardo Vilar, Jose Perez-Garcia, Josep TaberneroAnnals of Surgical Oncology|September 21, 2010
Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER databaseMin Yi, Sharon Hermes Giordano, Funda Meric-Bernstam, et al.Cell|January 9, 2018
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell SequencingAnna K Casasent, Aislyn Schalck, Ruli Gao, et al.Breast Cancer Research : BCR|October 30, 2012
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancerFunda Meric-Bernstam, Huiqin Chen, Argun Akcakanat, et al.American Journal of Surgery|April 14, 2009
Margin assessment after neoadjuvant chemotherapy in invasive lobular cancerJamie Wagner, Judy C Boughey, Betsy Garrett, et al.Annals of Surgical Oncology|November 16, 2023
Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast CancerAshley A Woodfin, Clinton Yam, Mediget Teshome, et al.NPJ Breast Cancer|November 7, 2022
Molecular differences between younger versus older ER-positive and HER2-negative breast cancersTao Qing, Thomas Karn, Mariya Rozenblit, et al.Recent Patents on Anti-Cancer Drug Discovery|June 10, 2008
Aurora kinase family: a new target for anticancer drugTeresa Macarulla, Francisco Javier Ramos, Josep TaberneroPageof 169